###begin article-title 0
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 63 68 <span type="species:ncbi:9606">human</span>
Association analysis of a highly polymorphic CAG Repeat in the human potassium channel gene KCNN3 and migraine susceptibility
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 228 234 228 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
Migraine is a polygenic multifactorial disease, possessing environmental and genetic causative factors with multiple involved genes. Mutations in various ion channel genes are responsible for a number of neurological disorders. KCNN3 is a neuronal small conductance calcium-activated potassium channel gene that contains two polyglutamine tracts, encoded by polymorphic CAG repeats in the gene. This gene plays a critical role in determining the firing pattern of neurons and acts to regulate intracellular calcium channels.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 518 524 518 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 305 313 <span type="species:ncbi:9606">patients</span>
The present association study tested whether length variations in the second (more 3') polymorphic CAG repeat in exon 1 of the KCNN3 gene, are involved in susceptibility to migraine with and without aura (MA and MO). In total 423 DNA samples from unrelated individuals, of which 202 consisted of migraine patients and 221 non-migraine controls, were genotyped and analysed using a fluorescence labelled primer set on an ABI310 Genetic Analyzer. Allele frequencies were calculated from observed genotype counts for the KCNN3 polymorphism. Analysis was performed using standard contingency table analysis, incorporating the chi-squared test of independence and CLUMP analysis.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 228 230 228 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 336 338 336 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 454 456 454 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 567 569 567 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 580 582 580 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 626 628 626 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Overall, there was no convincing evidence that KCNN3 CAG lengths differ between Caucasian migraineurs and controls, with no significant difference in the allelic length distribution of CAG repeats between the population groups (P = 0.090). Also the MA and MO subtypes did not differ significantly between control allelic distributions (P > 0.05). The prevalence of the long CAG repeat (>19 repeats) did not reach statistical significance in migraineurs (P = 0.15), nor was there a significant difference between the MA and MO subgroups observed compared to controls (P = 0.46 and P = 0.09, respectively), or between MA vs MO (P = 0.40).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 126 132 126 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
This association study provides no evidence that length variations of the second polyglutamine array in the N-terminus of the KCNN3 channel exert an effect in the pathogenesis of migraine.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 755 760 <span type="species:ncbi:9606">women</span>
###xml 774 777 <span type="species:ncbi:9606">men</span>
Migraine is a common, debilitating neurovascular disease characterised by severe recurrent headache, nausea and vomiting, photophobia and phonophobia [1]. It is clinically diagnosed based on criteria specified by the International Headache Society (IHS), defining two major classes of migraine: migraine with aura (MA) and migraine without aura (MO). MA sufferers experience neurovascular disturbances that precede the headache phase of an attack. Although migraine is partly influenced by environmental determinants, there is a significant genetic component, with disease heritability estimated to be up to 60% [2] and mode of transmission multifactorial. The disorder is common with a large Dutch study reporting lifetime prevalence estimates of 33% in women and 13.3% in men [3].
###end p 11
###begin p 12
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
Allelic candidate gene, studies provide the most suitable method for locating genes of small effect contributing to complex genetic disorders, such as migraine [4,5]. In particular, association studies are most powerful when a plausible candidate gene and a sequence variant with potential functional relevance is examined [6].
###end p 12
###begin p 13
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 355 363 355 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CACNA1A </italic>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 542 549 542 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP1A2 </italic>
###xml 615 616 615 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 623 630 623 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP1A2 </italic>
###xml 686 687 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 690 692 690 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1033 1035 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1042 1050 1042 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CACNA1A </italic>
###xml 1054 1061 1054 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP1A2 </italic>
###xml 1222 1224 1222 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1225 1227 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1241 1248 1241 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP1A2 </italic>
###xml 1443 1444 1443 1444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1607 1609 1607 1609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1622 1624 1622 1624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1785 1788 1785 1788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 1789 1791 1789 1791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1798 1804 1798 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 1910 1916 1910 1916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP1A2</italic>
###xml 2085 2087 2085 2087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2373 2375 2373 2375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 2376 2378 2376 2378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2676 2678 2676 2678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 2685 2687 2685 2687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2755 2760 2755 2760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3</italic>
###xml 2928 2930 2928 2930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 236 242 <span type="species:ncbi:9606">humans</span>
Mutations in various ion channel genes are responsible for neuromuscular and other neurological disorders. Inherited ion channel mutations or "channelopathies" are increasingly found to be the cause of various neurological disorders in humans (see review [7]). In familial hemiplegic migraine (FHM), a rare subtype of migraine with aura, mutations in the CACNA1A gene (localised at C19p13) have been found (FHM1) [8]. This gene codes for the alpha1A subunit of the neuronal voltage-dependent P/Q-type calcium channel. Recently a second gene, ATP1A2 (FHM2) (localised at C1q23), was implicated in some FHM families [9]. The ATP1A2 ion channel gene, codes for the alpha2 subunit of the Na+, K+ ion ATPase pump. These findings of mutations in these genes have focused attention on central nervous system ionic channels and helped to better understand FHM pathophysiology [10], where the best genetic evidence providing molecular insight into migraine still comes from the mutations detected in the rare form of migraine with aura; FHM [11]. The CACNA1A and ATP1A2 genes have both previously been tested in the common forms of migraine, but no new mutations or the FHM mutations were detected in these MA/MO affected samples [12-14]. Since FHM2-ATP1A2 is partly a potassium channel gene and is localised nearby to the potassium channel KCNN3, it may be interesting to investigate this gene in the common forms of migraine. In general, potassium (K+) channels set the resting membrane potential and regulate the action potential, whereby they control neuronal excitability. The small conductance (SK) calcium (Ca2+) activated K+ channels are responsible for the "after-hyperpolarization" of neurons, which follows a train of action potentials, being activated by the increase in neuronal Ca2+ [15]. The KCNN3 gene (C1q21.3) (a neuronal small conductance calcium-activated potassium channel, localised close to FHM2-ATP1A2;C1q23) encodes a protein of 731 amino acids containing two adjacent polyglutamine arrays (encoded by CAG repeats) in its N-terminal domain separated by 25 amino acids [16]. The first CAG repeat, coding for a polyglutamine stretch in exon 1 at nucleotide 88, also contains a CAA sequence anomaly after 7 repeats of CAG. However this CAG repeat region is not suitable for association studies as it is only slightly polymorphic having usually 12 CAG repeats [15,16]. The second, C-terminal, polyglutamine array, located 111 nucleotides downstream from the initial CAG repeat of the first polyglutamine stretch in exon 1, is highly polymorphic in Caucasian populations with a modal allele length of 19 and a repeat range of 10 to 28 glutamine - CAG repeats [see [15] and [16]]. Small conductance calcium-activated potassium channels (such as KCNN3) play a critical role in determining the firing pattern of neurons via the generation of slow after-polarization and the regulation of intracellular calcium channels [17].
###end p 13
###begin p 14
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3</italic>
###xml 29 31 29 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 183 189 183 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 234 240 234 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 371 379 367 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CACNA1A </italic>
###xml 419 420 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 487 489 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 530 532 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
KCNN3, localized at C1q21.3 [15], is positioned close to familial hemiplegic migraine (FHM) type 2, C1q23 [9,18], which is a severe autosomal dominant type of MA [1]. In 1999, Austin et al [19] suggested a mechanistic analogy for the KCNN3 polymorphism may be the small polyglutamine number variations in the calcium channel alpha1a subunit, encoded by CAG expansions in CACNA1A (a calcium channel implicated in FHM1) [8] which are thought to cause Spinocerebellar ataxia type 6 (SCA6) [20] by loss of channel function mechanism [21].
###end p 14
###begin p 15
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
Polymorphic CAG repeats in the KCNN3 channels affect the regulation of intracellular calcium channels [17]. Since calcium channels regulate numerous processes critical to neuronal function including secretion of neurotransmitters [22], abnormal alterations in calcium channels can cause alterations in the release of neurotransmitters such as serotonin, norepinephrine, and dopamine, which all have been shown to be involved in migraine disease [23-25].
###end p 15
###begin p 16
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 150 156 150 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 414 420 414 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 496 504 <span type="species:ncbi:9606">patients</span>
Given that FHM2 maps to C1q23 and KCNN3 localizes nearby at C1q21.3, it may be important to examine the prevalence of the second (highly polymorphic) KCNN3 CAG polymorphism in populations affected and unaffected with migraine. In the current study, we investigated the possibility of an association between migraine (MA and MO affected) and the second (more 3') CAG repeat polymorphism length variation within the KCNN3 gene, using a case-control study of unrelated Australian Caucasian migraine patients and ethnically matched controls.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
Subjects
###end title 18
###begin p 19
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
This study was approved by the Griffith University Ethics Committee and all subjects who participated gave informed consent. The subjects chosen were of Caucasian origin and were categorised based on the diagnostic criteria specified by the International Headache Society (IHS) [1]. Migraine individuals were diagnosed as having migraine with aura (MA) and migraine without aura (MO) from questionnaires and interviews conducted by an experienced clinical neurologist (JM).
###end p 19
###begin p 20
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 173 181 <span type="species:ncbi:9606">patients</span>
In total, 423 DNA samples from unrelated individuals were analysed, of which 202 consisted of migraine patients and 221 non-migraine controls. Of the affected group, 90% of patients had a known family history of migraine, or at least one affected first degree relative. Clinically, the affected group had an average age of approximately 18 yrs disease onset, while average duration of migraine was 20 hours and frequencies of approximately 30 attacks per year. The unaffected control group was recruited from the same geographical location (East Coast of Australia) as the affected group and was matched to the case samples for variables of age (+/- 5 years), gender and ethnicity (Caucasian). This reduces the possibility of spurious results due to underlying population stratification. Individuals that reported being affected with known migraine comorbid conditions such as mental illness (eg. depression) and cardiovascular disease (eg. stroke) were excluded from the test groups.
###end p 20
###begin title 21
Genotyping
###end title 21
###begin p 22
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 123 129 123 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 445 449 436 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 519 523 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 572 573 560 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 907 909 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
Genomic DNA was isolated from whole blood by a standard salting out procedure [26,27]. DNA fragments containing the second KCNN3 CAG polymorphism were amplified by PCR using the oligonucleotides published by Austin et al, 1999 [19]. The sense primer sequence was 5'-CAG CAG CCC CTG GGA CCC TCG C-3', and the anti-sense 5'-GGA GTT GGG CGA GCT GAG ACA G-3'. PCR constituents consisted of the following; 1X buffer J (Master Amptrade mark, EPICENTRE(R) Technologies), 0.2 muM each of forward and reverse primers, 1 unit of Taq polymerase and 40 ng of genomic DNA, mixed with H20 in a final volume of 10 ul. Thermal cycler parameters consisted of 1 cycle at 95degreesC for 4 min, for initial denaturation, followed by 35 cycles of denaturation for 1 min at 94degreesC, primer annealing at 55degreesC for 1 min and primer extension at 72degreesC for 30 sec. Final PCR extension consisted of 72degreesC for 2 min [19].
###end p 22
###begin p 23
The DNA samples were genotyped using an ABI PRISMtrade mark 310 Genetic Analyzer and a FAM fluorescent dye labelled forward primer (utilized in the PCR reaction). Raw data was imported into the ABI PRISMtrade mark Genotyper v2.0 DNA Fragment Analysis Software, whereby genotypes were individually called. Independent quality control analysis, performed by a laboratory technician, for the CAG variant consisted of PCR and genotyping of a random selection of 50 cases and controls to test for any differences between initial genotype data.
###end p 23
###begin title 24
Statistical analysis
###end title 24
###begin p 25
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
Allele frequencies were calculated from observed genotype counts for the KCNN3 polymorphism. The frequencies for the KCNN3 gene variant were initially assessed for association with migraine using standard contingency table analysis, incorporating the chi-squared test of independence. CLUMP analysis [28], useful for association testing when markers produce sparse contingency tables, was applied to test differences in the allelic distribution between the groups of migraine and controls patients. A two-tailed type I error rate of 5% was chosen for the analyses. Data were analysed by methods described previously, based on the mode of distribution of alleles, with a modal repeat length of 19 CAG repeats [16] and the hypothesis of an association between migraine and larger repeats (>19) analysed by chi-square analysis. Allele sizes were divided into long and short groups with respect to being greater than 19 repeats or equal to and less than 19 CAG repeats in length.
###end p 25
###begin title 26
Results
###end title 26
###begin p 27
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 610 616 610 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 762 764 762 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 781 782 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 885 887 885 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1157 1159 1157 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1176 1177 1176 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1315 1321 1315 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 1398 1400 1398 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1417 1418 1417 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1448 1450 1448 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1703 1705 1703 1705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 161 169 <span type="species:ncbi:9606">patients</span>
###xml 174 182 <span type="species:ncbi:9606">patients</span>
###xml 387 395 <span type="species:ncbi:9606">patients</span>
The distribution of allele frequencies for migraine patients compared to controls are displayed in Figure 1, with the distributions of allele frequencies for MA patients, MO patients and controls displayed in Figure 2. Both figures show CAG repeat number along the X-axis versus frequency of distributions (%) displayed along the Y-axis. The repeat range is 12 to 24 repeats in migraine patients, not including the repeat lengths of 22 and 23. For the controls the range is 12 to 26 repeats, except for the 24 CAG repeat size. This displays the highly polymorphic nature of the second CAG expansion within the KCNN3 gene. No significant differences in allelic distributions were observed between the migraine and control groups for standard chi-square analysis (P = 0.090) (Figure 1). Clump analysis, for normal chi-square, also showed no significant difference reported (T1 = 20.111, P = 0.090). However for chi-square clumped 2x2 table analysis (obtained by clumping the columns of the original table to maximise the chi-squared value) [28], between migraine and controls, slightly significant differences were detected within the test data (T4 = 13.001, P = 0.037) (Figure 1). This indicates that there maybe a slight significant difference between the case-control populations with regards to clumped 2x2 table KCNN3 allele distributions. The T3 statistic was also positive for CLUMP analysis (P = 0.025) (Figure 1), although, Sham and Curtis [28] recommends that either normal chi-squared (T1) or chi-squared for "clumped" 2x2 table (T4) analysis should be used. The other two statistics (T2, T3) may lack power to detect association in data sets studied, whereas T1 and T4 perform similarly well [28].
###end p 27
###begin p 28
###xml 156 158 156 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 195 197 195 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 322 323 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">I</xref>
###xml 350 355 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 363 365 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 501 503 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 671 673 669 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 806 807 804 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1073 1075 1071 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1086 1088 1084 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1132 1134 1130 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1149 1150 1147 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">I</xref>
###xml 133 141 <span type="species:ncbi:9606">patients</span>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
When dividing migraine affected samples into the subtypes MA and MO, distribution of alleles did not differ significantly between MA patients and controls (P > 0.05) or MO patients and controls (P > 0.05) (Figure 2). Analysis was also performed by distributing the alleles into </=19 (short) and >19 repeats (long) (Table I), described as per Chandy et al, 1998 [16]. The hypothesis of the presence of very long CAG repeats might be expected for a disorder relating to trinucleotide repeat expansion [16]; this was tested by chi-square analysis. Migraine probands showed no significant difference in allelic length distribution of the CAG repeats compared with controls (P = 0.15). Though the number of long CAG repeats (>19 repeats) was higher in the migraine group (92 compared to 83 for controls, Table 1) and the incidence of the CAG short repeat (<19 repeats) was higher in the control (359) group than in the migraine (312) group. Similarly, the allele frequency distributions for the migraine subgroups, MA and MO compared to controls did not approach significance (P = 0.46 and P = 0.09, respectively), or between MA vs MO (P = 0.40) (Table I).
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
Polyglutamine disorders are due to CAG repeat expansions that cause a toxic gain of function of mutant expanded proteins, in which protein misfolding, interference with DNA transcription and RNA processing, activation of apoptosis and dysfunction of cytoplasmic elements have all been invoked in the toxic process. [29]. These CAG expansions have been involved in a number of neurological diseases, including Huntington's disease (HD), Dentatorubralpallidoluysian atrophy (DRPLA), Kennedy's disease and Spinocerebellar ataxia (SCA) 1-3, 6-7, 12 and 17 [29].
###end p 30
###begin p 31
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 395 403 395 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CACNA1A </italic>
###xml 429 430 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 565 571 565 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 968 974 968 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 1345 1347 1345 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1348 1350 1348 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 728 736 <span type="species:ncbi:9606">Patients</span>
Migraine is a polygenic multifactorial disease influenced by genetic and lifestyle characteristics. At present the mode(s) of inheritance is unclear and the type and number of migraine genes involved in the disease is not known. Since both FHM and familial typical migraine (FTM) display some clinical overlap [1], it is thought that the more prevalent FTM may also be a channelopathy [30]. The CACNA1A gene, involved with FHM1 [8] controls a number of fundamental neuronal processes including mediation and release of neurotransmitters such as serotonin [31]. The KCNN3 gene acts to regulate the firing pattern of neurons via the generation of slow after-polarization and the regulation of intracellular calcium channels [17]. Patients with migraine have autonomic nervous system dysfunction and altered levels of neurotransmitters. Therefore, decreases in activity and regulation of intracellular calcium channels, that may be caused by CAG repeat expansions in the KCNN3 gene, would result in decreased levels of neurotransmitters (such as serotonin) and autonomic nervous system dysfunction. These states appear to be analogous to those found during migraine headache in that decreases in plasma levels of serotonin would essentially act to constrict the arterioles, therefore causing dilation of the larger arteries, possibly causing pain [32,33].
###end p 31
###begin p 32
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 242 247 <span type="species:ncbi:9606">women</span>
###xml 261 264 <span type="species:ncbi:9606">men</span>
Wittekindt et al, 1998 [15] reported that the KCNN3 gene is a good candidate for schizophrenia and bipolar disorder (BD), as well as for other neurological disorders. This includes migraine, a painful neurological disease that affects 33% of women and 13.3% of men [3].
###end p 32
###begin p 33
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 572 578 572 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 944 946 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1354 1355 1354 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">I</xref>
###xml 1401 1403 1401 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1447 1452 1447 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1460 1462 1460 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1637 1639 1637 1639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1665 1667 1665 1667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1799 1801 1799 1801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 2052 2053 2052 2053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 2058 2059 2058 2059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 2395 2396 2395 2396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 2494 2496 2494 2496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 2761 2763 2761 2763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 2874 2875 2874 2875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 3014 3019 3014 3019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3</italic>
###xml 264 272 <span type="species:ncbi:9606">patients</span>
###xml 586 594 <span type="species:ncbi:9606">patients</span>
###xml 1065 1073 <span type="species:ncbi:9606">patients</span>
###xml 1171 1179 <span type="species:ncbi:9606">patients</span>
However, even though there was a slight indication of significance in one analysis (clump T4 statistic) [28], overall the results of this study proved that there was no statistically significant association between allelic frequencies of migraine and non-migraine patients. Also no significant difference in allelic frequencies was observed in the migraine subtypes, MA and MO when compared to the control population. There have been many contradicting studies that have shown a significant over-representation or non-significant representation of long CAG repeats in the KCNN3 gene in patients with schizophrenia and bipolar disease compared to population controls [see [34]]. In a meta-analysis of association studies for schizophrenia and bipolar disorder with the CAG-repeat length in KCNN3, the results demonstrated that the risks for both of these disorders were largely, if not entirely, independent of the CAG-repeat in the KCNN3 gene [34]. This study examined CAG repeat lengths (the second, C-terminal, polyglutamine array in exon 1 of KCNN3) in migraine patients and also found no significant evidence to suggest long CAG repeats (>19) are over-represented in patients with migraine compared to controls, even though there was a higher incidence reported for long CAG repeat (>19 repeats) in the migraine group compared to the controls (Table I), it did not reach statistical significance (P < 0.05). However, a recent study by Mossner et al, 2005 [35], reported an association between the second highly polymorphic polyglutamine stretch and migraine. In this study the authors found allele 15 to be associated with migraine (P = 0.027; total migraine) [35]. Allele 15 is extremely rare with a 1.6% frequency in MA, 1.5% in MO and a 0.2% control frequency found in Mossner et al's study [35]. In our investigation of the second KCNN3 - CAG repeat we found a frequency in allele 15 of 0.9% in MA (only 2 out of 222 alleles), 1.65% in MO (3 out of 182 alleles) and 0.9% in controls (4 out of 442 alleles) (see distribution of alleles, Figures 1 and 2). From the two studies it can be seen that this allele is too rare to make any assumptions of whether it is migraine related. A population base far greater in number is needed in order to obtain meaningful data from allele 15. Also, the fact that this study utilised samples that were all carefully diagnosed following IHS guidelines [1], including all samples from the migraine unaffected-control population and Mossner et al, 2005 [35] did not, leaves their positive results questionable. Mossner et al had made a migraine-unaffected assumption with more than half their controls (119/232 samples). These individuals that were utilised as controls, were an undiagnosed, anonymous blood donor group [35], that were not directly interviewed or diagnosed according to the International Headache Society guidelines [1]. This could have a tremendous impact on the outcomes of their study, due to the rarity of allele 15 in the second CAG repeat of exon1 in KCNN3.
###end p 33
###begin p 34
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
The present association study was conducted in carefully diagnosed (according to IHS guidelines [1]), age, sex and ethnicity matched case-control populations. However the results provided no evidence that KCNN3 gene confers susceptibility to the subtypes of migraine (MA and MO), or common migraine.
###end p 34
###begin title 35
Conclusion
###end title 35
###begin p 36
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 164 170 164 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
We conclude that our data does not confer with Mossner et al, 2005 [35], providing no evidence that a variation at the polymorphic, second CAG repeat locus, in the KCNN3 gene, influences susceptibility to migraine, or to the migraine subtypes, MA and MO.
###end p 36
###begin title 37
List of abbreviations
###end title 37
###begin p 38
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
KCNN3 neuronal small conductance calcium-activated potassium channel, subfamily N, member 3, MA migraine with aura, MO migraine without aura.
###end p 38
###begin title 39
Competing interests
###end title 39
###begin p 40
The author(s) declare that they have no competing interests.
###end p 40
###begin title 41
Authors' contributions
###end title 41
###begin p 42
###xml 238 245 <span type="species:ncbi:9606">patient</span>
RC carried out the optimisation of this molecular genetic study and drafted the manuscript. JS carried out PCR and genotyping. RL carried out statistical analysis. MO carried out DNA sample preparation for the populations. JM carried out patient clinical diagnosis. LG conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 42
###begin title 43
Pre-publication history
###end title 43
###begin p 44
The pre-publication history for this paper can be accessed here:
###end p 44
###begin p 45

###end p 45
###begin article-title 46
The international classification of headache disorders: 2nd edition
###end article-title 46
###begin article-title 47
The inheritance of migraine with aura estimated by means of structural equation modelling
###end article-title 47
###begin article-title 48
The prevalence and characteristics of migraine in a population-based cohort: the GEM study
###end article-title 48
###begin article-title 49
Association and linkage: complimentary strategies for complex disorders
###end article-title 49
###begin article-title 50
###xml 41 46 <span type="species:ncbi:9606">human</span>
The future of genetic studies of complex human diseases
###end article-title 50
###begin article-title 51
Association versus linkage studies in psychosis genetics
###end article-title 51
###begin article-title 52
Neurological disorders caused by inherited ion-channel mutations
###end article-title 52
###begin article-title 53
###xml 105 113 105 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CACNL1A4</italic>
Familial hemiplegic migraine and episodic ataxia type2 are caused by mutations in the Ca2 + channel gene CACNL1A4
###end article-title 53
###begin article-title 54
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP1A2 </italic>
Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha-2 subunit associated with familial hemiplegic migraine type 2
###end article-title 54
###begin article-title 55
[Genetics of migraines: from ionic channels to single nucleotide polymorphisms?]
###end article-title 55
###begin article-title 56
The molecular genetics of migraine
###end article-title 56
###begin article-title 57
Investigation of the CACNA1A gene as a candidate for typical migraine susceptibility
###end article-title 57
###begin article-title 58
No mutations in CACNA1A and ATP1A2 in probands with common types of migraine
###end article-title 58
###begin article-title 59
Analysis of Chromosome 1 Microsatellite Markers and the FHM-2 (ATP1A2 Gene) Mutations in Migraine With and Without Aura Pedigrees
###end article-title 59
###begin article-title 60
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSKCs3</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human small conductance calcium-regulated potassium channel gene (hSKCs3) contains two CAG repeats in exon 1, is on chromosome 1q21.3, and shows a possible association with schizophrenia
###end article-title 60
###begin article-title 61
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSKCa3 </italic>
Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate gene for schizophrenia and bipolar disorder
###end article-title 61
###begin article-title 62
Small-conductance, calcium-activated potassium channels from mammalian brain
###end article-title 62
###begin article-title 63
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP1A4</italic>
###xml 45 50 <span type="species:ncbi:9606">human</span>
Physical mapping and characterization of the human Na, K-ATPase isoform, ATP1A4
###end article-title 63
###begin article-title 64
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
Mapping of KCNN3 to chromosome 1q21 and investigation of linkage of CAG repeat polymorphism to schizophrenia
###end article-title 64
###begin article-title 65
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCA6</italic>
Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel
###end article-title 65
###begin article-title 66
Spinocerebellar ataxia type 6: channelopathy or glutamine repeat disorder?
###end article-title 66
###begin article-title 67
Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies
###end article-title 67
###begin article-title 68
Migraine: pathophysiology, pharmacology, treatment and future trends
###end article-title 68
###begin article-title 69
Migraine: a chronic sympathetic nervous system disorder
###end article-title 69
###begin article-title 70
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DBH</italic>
Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine
###end article-title 70
###begin article-title 71
Isolation of high molecular-weight DNA
###end article-title 71
###begin article-title 72
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells
###end article-title 72
###begin article-title 73
Monte Carlo tests for associations between disease and alleles at highly polymorphic loci
###end article-title 73
###begin article-title 74
Trinucleotide repeats and neurodegenerative disease
###end article-title 74
###begin article-title 75
The impact of pharmacogenetics for migraine
###end article-title 75
###begin article-title 76
###xml 60 65 <span type="species:ncbi:9606">human</span>
Calcium channel subtypes controlling serotonin release from human cell lung carcinoma cell line
###end article-title 76
###begin article-title 77
Migraine
###end article-title 77
###begin article-title 78
Neural processing of cardiovascular pain: a synthesis of the central structures involved in migraine
###end article-title 78
###begin article-title 79
CAG-repeat length in exon 1 of KCNN3 does not influence risk for schizophrenia or bipolar disorder: a meta-analysis of association studies
###end article-title 79
###begin article-title 80
A highly polymorphic poly-glutamine stretch in the potassium channel KCNN3 in migraine
###end article-title 80
###begin title 81
Figures and Tables
###end title 81
###begin p 82
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
Distribution of allele frequencies by CAG repeat number for the second CAG polymorphism of the KCNN3 gene observed in migraine and control groups.
###end p 82
###begin p 83
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3 </italic>
Distribution of allele frequencies by CAG repeat number for the second CAG polymorphism of the KCNN3 gene observed in migraine subtypes (MA and MO) and control groups.
###end p 83
###begin p 84
###xml 75 80 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNN3</italic>
Long (>19 repeats) and short (</=19 repeats) alleles: CAG repeat number in KCNN3; analysis performed utilising the comparison of long and short allele repeat numbers between migraine and control populations.
###end p 84
###begin p 85
###xml 115 117 115 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 142 144 142 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 169 171 169 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 201 203 201 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
* Analysis of long and short alleles: no significant differences were obtained between migraine vs control groups (P = 0.15), MA vs controls (P = 0.46), MO vs controls (P = 0.09), or between MA vs MO (P = 0.40)
###end p 85

